Interleukin-27 mediates inflammation during chronic disease

Journal of Interferon and Cytokine Research

Volumn 34, Issue 10, 2014, Pages 741-749

  Wynick, Christopher ^a   Petes, Carlene ^a   Gee, Katrina ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 27; INTERLEUKIN 35; TOLL LIKE RECEPTOR; AUTACOID;

ADAPTIVE IMMUNITY; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL TRANSFER; CHRONIC DISEASE; COLITIS; CYTOKINE PRODUCTION; DERMATITIS; HUMAN; INFLAMMATORY BOWEL DISEASE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; TH1 CELL; TH17 CELL; ANIMAL; AUTOIMMUNITY; IMMUNOLOGY; INNATE IMMUNITY;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNITY; CHRONIC DISEASE; DERMATITIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-27;

EID: 84907903635     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0154     Document Type: Review

References (73)

1. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8 (12): 1380-1389.
2. Bancroft AJ, Else KJ, Sypek JP, Grencis RK. 1997. Interleukin- 12 promotes a chronic intestinal nematode infection. Eur J Immunol 27 (4): 866-870.
3. Bancroft AJ, Humphreys NE, Worthington JJ, Yoshida H, Grencis RK. 2004. WSX-1: a key role in induction of chronic intestinal nematode infection. J Immunol 172 (12): 7635-7641.
4. Bancroft AJ, McKenzie AN, Grencis RK. 1998. A critical role for IL-13 in resistance to intestinal nematode infection. J Immunol 160 (7): 3453-3461.
5. Batten M, Ghilardi N. 2007. The biology and therapeutic potential of interleukin 27. J Mol Med 85 (7): 661-672.
6. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7 (9): 929-936.
7. Baumgart DC, Sandborn WJ. 2012. Crohn's disease. Lancet 380 (9853): 1590-1605.
8. Bosmann M, Ward PA. 2013. Modulation of inflammation by interleukin-27. J Leukoc Biol 94 (6): 1159-1169.
9. Brender C, Tannahill GM, Jenkins BJ, Fletcher J, Columbus R, Saris CJ, Ernst M, Nicola NA, Hilton DJ, Alexander WS, Starr R. 2007. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. Blood 110 (7): 2528-2536.
10. Castellani ML, Anogeianaki A, Felaco P, Toniato E, De Lutiis MA, Shaik B, Fulcheri M, Vecchiet J, Tete S, Salini V, Theoharides TC, Caraffa A, Antinolfi P, Frydas I, Conti P, Cuccurullo C, Ciampoli C, Cerulli G, Kempuraj D. 2010. IL- 35, an anti-inflammatory cytokine which expands CD4+ CD25+ Treg Cells. J Biol Regul Homeost Agents 24 (2): 131-135.
11. Chakravortty D, Hensel M. 2003. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 5 (7): 621-627.
12. Christ AD, Stevens AC, Koeppen H, Walsh S, Omata F, Devergne O, Birkenbach M, Blumberg RS. 1998. An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease. Gastroenterology 115 (2): 307-313.
13. Collison LW, Pillai MR, Chaturvedi V, Vignali DA. 2009. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 182 (10): 6121-6128.
14. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (7169): 566-569.
15. Cox JH, Kljavin NM, Ramamoorthi N, Diehl L, Batten M, Ghilardi N. 2011. IL-27 promotes T cell-dependent colitis through multiple mechanisms. J Exp Med 208 (1): 115-123.
16. Diegelmann J, Olszak T, Goke B, Blumberg RS, Brand S. 2012. A novel role for IL-27 as mediator of intestinal epithelial barrier protection mediated via differential STAT signaling and induction of antibacterial and anti-inflammatory proteins. J Biol Chem 287 (1): 286-298.
17. Diveu C, McGeachy MJ, Boniface K, Stumhofer JS, Sathe M, Joyce-Shaikh B, Chen Y, Tato CM, McClanahan TK, de Waal, Malefyt R, Hunter CA, Cua DJ, Kastelein RA. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182 (9): 5748-5756.
18. El-behi M, Ciric B, Yu S, Zhang GX, Fitzgerald DC, Rostami A. 2009. Differential effect of IL-27 on developing versus committed Th17 cells. J Immunol 183 (8): 4957-4967.
19. Eyerich K, Novak N. 2013. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 68 (8): 974-982.
20. Feng XM, Chen XL, Liu N, Chen Z, Zhou YL, Han ZB, Zhang L, Han ZC. 2007. Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator. Hum Immunol 68 (12): 965-972.
21. Fitzgerald DC, Zhang GX, El Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8 (12): 1372-1379.
22. Freitas do Rosario AP, Lamb T, Spence P, Stephens R, Lang A, Roers A, Muller W, O'Garra A, Langhorne J. 2012. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol 188 (3): 1178-1190.
23. Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. 2009. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 8 (1): 40-52.
24. Gotlind YY, Fritsch, Fredin M, Kumawat AK, Strid H, Willen R, Rangel I, Bland PW, Hornquist EH. 2013. Interplay between T (h)1 and T (h)17 effector T-cell pathways in the pathogenesis of spontaneous colitis and colon cancer in the Galphai2-deficient mouse. Int Immunol 25 (1): 35-44.
25. Guzzo C, Ayer A, Basta S, Banfield BW, Gee K. 2012. IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes. J Immunol 188 (2): 864-873.
26. Guzzo C, Che Mat NF, Gee K. 2010. Interleukin-27 induces a STAT1/3 and NF-kappaB dependent proinflammatory cytokine profile in human monocytes. J Biol Chem 285 (32): 24404-24411.
27. Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, Stewart CA, Janelsins BM, Datta SK, Shen W, McLean MH, Durum SK. 2014. Oral delivery of IL27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology 156 (1): 210-221.
28. Helmby H, Takeda K, Akira S, Grencis RK. 2001. Interleukin (IL)-18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J Exp Med 194 (3): 355-364.
29. Hibbert L, Pflanz S, de Waal, Malefyt R, Kastelein RA. 2003. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce TBet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23 (9): 513-522.
30. Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174 (6): 3534-3544.
31. Honda K, Nakamura K, Matsui N, Takahashi M, Kitamura Y, Mizutani T, Harada N, Nawata H, Hamano S, Yoshida H. 2005. T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis. Inflamm Bowel Dis 11 (12): 1044-1052.
32. Huber M, Steinwald V, Guralnik A, Brustle A, Kleemann P, Rosenplanter C, Decker T, Lohoff M. 2008. IL-27 inhibits the development of regulatory T cells via STAT3. Int Immunol 20 (2): 223-234.
33. Hunter CA, Kastelein R. 2012. Interleukin-27: balancing protective and pathological immunity. Immunity 37 (6): 960-969.
34. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, Kugathasan S, Bradfield JP, Walters TD, Sleiman P, Kim CE, Muise A, Wang K, Glessner JT, Saeed S, Zhang H, Frackelton EC, Hou C, Flory JH, Otieno G, Chiavacci RM, Grundmeier R, Castro M, Latiano A, Dallapiccola B, Stempak J, Abrams DJ, Taylor K, McGovern D, Silber G, Wrobel I, Quiros A, Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmuda MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwillam R, Tremelling M, Delukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ, Heyman MB, Ferry GD, Kirschner B, Lee J, Essers J, Grand R, Stephens M, Levine A, Piccoli D, Van Limbergen J, Cucchiara S, Monos DS, Guthery SL, Denson L, Wilson DC, Grant SF, Daly M, Silverberg MS, Satsangi J, Hakonarson H. 2009. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 41 (12): 1335-1340.
35. Kalliolias GD, Ivashkiv LB. 2008. IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J Immunol 180 (9): 6325-6333.
36. Kanda N, Watanabe S. 2008. IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes. Eur J Immunol 38 (5): 1287-1296.
37. Kim G, Shinnakasu R, Saris CJ, Cheroutre H, Kronenberg M. 2013. A novel role for IL-27 in mediating the survival of activated mouse CD4 T lymphocytes. J Immunol 190 (4): 1510-1518.
38. Leon AJ, Gomez E, Garrote JA, Bernardo D, Barrera A, Marcos JL, Fernandez-Salazar L, Velayos B, Blanco-Quiros A, Arranz E. 2009. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm 2009: 580450.
39. Li HY, Zhang DL, Ge J, Zhou H, Qi, Ap, Ma L, Xue F, Zhou ZP, Yang RC. 2012. Elevated interleukin-27 enhances the polarization of Th1/Tc1 cells and the production of proinflammatory cytokines in primary immune thrombocytopenia. Hum Immunol 73 (3): 240-247.
40. Liu H, Rohowsky-Kochan C. 2011. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. J Interferon Cytokine Res 31 (5): 459-469.
41. Lowes MA, Bowcock AM, Krueger JG. 2007. Pathogenesis and therapy of psoriasis. Nature 445 (7130): 866-873.
42. Lucas S, Ghilardi N, Li J, de Sauvage FJ. 2003. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1- dependent and -independent mechanisms. Proc Natl Acad Sci U S A 100 (25): 15047-15052.
43. Maaser C, Egan LJ, Birkenbach MP, Eckmann L, Kagnoff MF. 2004. Expression of Epstein-Barr virus-induced gene 3 and other interleukin-12-related molecules by human intestinal epithelium. Immunology 112 (3): 437-445.
44. Moon SJ, Park JS, Heo YJ, Kang CM, Kim EK, Lim MA, Ryu JG, Park SJ, Park KS, Sung YC, Park SH, Kim HY, Min JK, Cho ML. 2013. In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis. Exp Mol Med 45: e46.
45. Murugaiyan G, Mittal A, Lopez-Diego R, Maier LM, Anderson DE, Weiner HL. 2009. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 183 (4): 2435-2443.
46. Neufert C, Becker C, Wirtz S, Fantini MC, Weigmann B, Galle PR, Neurath MF. 2007. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol 37 (7): 1809-1816.
47. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB, Liew FY. 2008. Interleukin-27 attenuates collagen-induced arthritis. Ann Rheum Dis 67 (10): 1474-1479.
48. Omata F, Birkenbach M, Matsuzaki S, Christ AD, Blumberg RS. 2001. The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease. Inflamm Bowel Dis 7 (3): 215-220.
49. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4- independent mechanism. Immunity 9 (5): 745-755.
50. Owaki T, Asakawa M, Kamiya S, Takeda K, Fukai F, Mizuguchi J, Yoshimoto T. 2006. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol 176 (5): 2773-2780.
51. Owaki T, Asakawa M, Morishima N, Hata K, Fukai F, Matsui M, Mizuguchi J, Yoshimoto T. 2005. A role for IL-27 in early regulation of Th1 differentiation. J Immunol 175 (4): 2191-2200.
52. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, Phillips JH, McClanahan TK, de Waal, Malefyt R, Kastelein RA. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172 (4): 2225-2231.
53. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal, Malefyt R, Rennick D, Kastelein RA. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 ( + ) T cells. Immunity 16 (6): 779-790.
54. Pot C, Apetoh L, Awasthi A, Kuchroo VK. 2011. Induction of regulatory Tr1 cells and inhibition of T (H)17 cells by IL-27. Semin Immunol 23 (6): 438-445.
55. Sasaoka T, Ito M, Yamashita J, Nakajima K, Tanaka I, Narita M, Hara Y, Hada K, Takahashi M, Ohno Y, Matsuo T, Kaneshiro Y, Tanaka H, Kaneko K. 2010. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. Am J Physiol Gastrointest Liver Physiol 300 (4): G568-G576.
56. Sattler A, Wagner U, Rossol M, Sieper J, Wu P, Krause A, Schmidt WA, Radmer S, Kohler S, Romagnani C, Thiel A. 2009. Cytokine-induced human IFN-gamma-secreting effector- memory Th cells in chronic autoimmune inflammation. Blood 113 (9): 1948-1956.
57. Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, Meuer SC, Stallmach A. 2005. Expression of interleukin- 12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin- 27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11 (1): 16-23.
58. Shibata S, Tada Y, Asano Y, Yanaba K, Sugaya M, Kadono T, Kanda N, Watanabe S, Sato S. 2013. IL-27 activates Th1- mediated responses in imiquimod-induced psoriasis-like skin lesions. J Invest Dermatol 133 (2): 479-488.
59. Shibata S, Tada Y, Kanda N, Nashiro K, Kamata M, Karakawa M, Miyagaki T, Kai H, Saeki H, Shirakata Y, Watanabe S, Tamaki K, Sato S. 2010. Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 130 (4): 1034-1039.
60. Shimizu M, Ogura K, Mizoguchi I, Chiba Y, Higuchi K, Ohtsuka H, Mizuguchi J, Yoshimoto T. 2013. IL-27 promotes nitric oxide production induced by LPS through STAT1, NFkappaB and MAPKs. Immunobiology 218 (4): 628-634.
61. Shimizu M, Shimamura M, Owaki T, Asakawa M, Fujita K, Kudo M, Iwakura Y, Takeda Y, Luster AD, Mizuguchi J, Yoshimoto T. 2006. Antiangiogenic and antitumor activities of IL-27. J Immunol 176 (12): 7317-7324.
62. Skroza N, Proietti I, Pampena R, La, Viola G, Bernardini N, Nicolucci F, Tolino E, Zuber S, Soccodato V, Potenza C. 2013. Correlations between psoriasis and inflammatory bowel diseases. Biomed Res Int 2013: 983902.
63. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, O'Shea JJ, Hennighausen L, Ernst M, Hunter CA. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7 (9): 937-945.
64. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8 (12): 1363-1371.
65. Troy AE, Zaph C, Du Y, Taylor BC, Guild KJ, Hunter CA, Saris CJ, Artis D. 2009. IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. J Immunol 183 (3): 2037-2044.
66. Villarino AV, Artis D, Bezbradica JS, Miller O, Saris CJ, Joyce S, Hunter CA. 2008. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. Int Immunol 20 (6): 739-752.
67. Visperas A, Do JS, Bulek K, Li X, Min B. 2013. IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice. Mucosal Immunol [Epub ahead of print]; DOI: 10.1038/mi.2013.82.
68. Wirtz S, Billmeier U, Mchedlidze T, Blumberg RS, Neurath MF. 2011. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141 (5): 1875-1886.
69. Wirtz S, Neurath MF. 2007. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59 (11): 1073-1083.
70. Wittmann M, Zeitvogel J, Wang D, Werfel T. 2009. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J Allergy Clin Immunol 124 (1): 81-89.
71. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura A, Yoshida H. 2006. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 177 (8): 5377-5385.
72. Zeitvogel J, Werfel T, Wittmann M. 2012. IL-27 acts as a priming signal for IL-23 but not IL-12 production on human antigen-presenting cells. Exp Dermatol 21 (6): 426-430.
73. Zhang J. 2007. Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease. J Clin Invest 117 (4): 871-873.